V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10457148 | 10034665 | 1.73 | 67 | Neo-adjuvant (N) | 2020-06-18 | 2020-06-23 | Capecitabine | 2 | null | CAPECITABINE | 101341554 |
| 10457169 | 10034666 | 1.74 | 48 | Palliative (P) | 2019-07-29 | 2019-08-05 | Docetaxel | 02 | N | DOCETAXEL | 101099418 |
| 10457174 | 10034667 | 1.57 | 80.3 | null | 2017-01-02 | 2019-04-24 | IBRUTINIB | 02 | null | IBRUTINIB | 101774392 |
| 10457185 | 10034668 | 1.68 | 84.7 | Palliative (P) | 2021-07-22 | 2021-08-01 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE + OXALIPLATIN | 101304930 |
| 10457195 | 10034669 | 1.58 | 75.3 | Palliative (P) | 2016-01-18 | 2016-02-08 | Rituximab (Maintenance) | 02 | N | RITUXIMAB | 101356386 |
| 10457196 | 10034670 | 1.73 | 106 | Neo-adjuvant (N) | 2020-11-22 | 2020-12-05 | Rituximab | 02 | null | RITUXIMAB | 100411873 |
| 10457200 | 10034671 | 1.62 | null | Palliative (P) | 2017-11-02 | 2017-11-02 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100342742 |
| 10457220 | 10034672 | 1.79 | 81 | 03 | 2019-05-16 | 2019-06-02 | PEMBROLIZUMAB | N | N | PEMBROLIZUMAB | 101684725 |
| 10457229 | 10034673 | 1.7 | 88 | Palliative (P) | 2019-01-04 | 2019-01-04 | CAPECITABINE + OXALIPLATIN | 02 | N | PEMBROLIZUMAB | 101608641 |
| 10457232 | 10034674 | 1.85 | 83 | Neo-adjuvant (N) | 2017-09-12 | 2017-09-12 | CAPECITABINE + OXALIPLATIN | N | N | CAPECITABINE + OXALIPLATIN | 101068220 |
| 10457249 | 10034675 | 1.46 | 94.3 | null | 2019-12-11 | 2020-01-24 | CAPECITABINE + OXALIPLATIN | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100561322 |
| 10457251 | 10034676 | 1.66 | 65.2 | Neo-adjuvant (N) | 2020-01-26 | 2020-01-26 | Capecitabine + Oxaliplatin 14day | 02 | null | CAPECITABINE | 100154709 |
| 10457265 | 10034677 | 1.63 | 71.2 | Palliative (P) | null | 2021-02-19 | IBRUTINIB | 02 | N | IBRUTINIB | 101564223 |
| 10457284 | 10034678 | 1.61 | 73.8 | Neo-adjuvant (N) | 2019-04-02 | 2019-04-13 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100514108 |
| 10457300 | 10034679 | 1.56 | 101 | null | 2019-12-29 | 2020-01-15 | Capecitabine + Oxaliplatin 21day | 99 | null | CAPECITABINE | 101012990 |
| 10457312 | 10034680 | 1.73 | 69.5 | null | 2022-01-29 | 2022-01-30 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE | 101382818 |
| 10457326 | 10034681 | 1.7 | 70 | Palliative (P) | 2020-12-22 | 2020-12-22 | Capecitabine + Oxaliplatin 21day | 02 | N | DOCETAXEL | 101584009 |
| 10457331 | 10034682 | 1.75 | 0 | Adjuvant (A) | 2019-07-10 | 2019-08-06 | IBRUTINIB | 02 | N | IBRUTINIB | 100713935 |
| 10457336 | 10034683 | 1.7 | 76.2 | null | null | 2021-11-01 | CAPECITABINE + OXALIPLATIN | 02 | null | PEMBROLIZUMAB | 100585722 |
| 10457341 | 10034684 | 1.74 | 71 | Curative (C) | 2017-09-10 | 2017-09-11 | Rituximab (SUBCUTANEOUS Maintenance) | 99 | N | RITUXIMAB | 100963391 |
| 10457369 | 10034685 | 1.6 | 79.4 | 03 | 2016-07-16 | 2016-07-18 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 100626786 |
| 10457388 | 10034686 | 1.66 | 97 | Curative (C) | 2019-01-18 | 2019-01-19 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101233887 |
| 10457419 | 10034687 | 1.73 | 99.95 | 03 | 2018-06-20 | 2018-06-21 | PEMBROLIZUMAB | N | N | RITUXIMAB | 101703144 |
| 10457450 | 10034688 | 0 | 0 | Curative (C) | 2014-01-30 | 2014-02-20 | Docetaxel | 02 | N | DOCETAXEL | 101557732 |
| 10457466 | 10034689 | 1.57 | 82 | Disease modification (D) | 2015-12-27 | 2015-12-29 | Capecitabine | 02 | N | CAPECITABINE | 101232754 |
| 10457468 | 10034690 | 1.69 | 80.6 | Disease modification (D) | 2014-11-25 | 2014-12-07 | Docetaxel | N | N | DOCETAXEL | 100635180 |
| 10457477 | 10034691 | 1.59 | 42 | null | 2021-12-09 | 2021-12-09 | Capecitabine | 99 | null | CAPECITABINE | 101070568 |
| 10457488 | 10034692 | 1.8 | 104.9 | null | 2016-08-02 | 2016-08-02 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100130612 |
| 10457510 | 10034693 | 1.65 | 83.5 | 03 | 2017-10-05 | 2017-10-05 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101203065 |
| 10457512 | 10034694 | 1.77 | 81.3 | Curative (C) | 2014-08-11 | 2014-08-23 | Capecitabine + Oxaliplatin 21day | N | N | CAPECITABINE + OXALIPLATIN | 100298340 |
| 10457514 | 10034695 | null | 193 | Palliative (P) | 2020-12-26 | 2021-01-02 | IBRUTINIB | 02 | N | IBRUTINIB | 101153841 |
| 10457523 | 10034696 | 1.6 | 89 | null | 2019-10-21 | 2019-10-21 | CHOP R - 21 days | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100482530 |
| 10457531 | 10034697 | 1.64 | 62.8 | 03 | 2019-01-05 | 2019-01-16 | Capecitabine + Oxaliplatin 21day | 02 | N | PEMBROLIZUMAB | 100162956 |
| 10457540 | 10034698 | 1.82 | 0 | Adjuvant (A) | 2017-03-07 | 2017-03-20 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 101577349 |
| 10457542 | 10034699 | 1.71 | 70.6 | null | 2020-02-02 | 2020-02-02 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101069405 |
| 10457565 | 10034700 | 1.58 | null | Palliative (P) | 2018-06-15 | 2018-06-15 | IBRUTINIB | 02 | N | PEMBROLIZUMAB | 101007723 |
| 10457598 | 10034701 | 1.77 | 48.6 | Palliative (P) | 2019-02-06 | 2019-02-06 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE | 101715859 |
| 10457612 | 10034702 | 1.74 | 89.9 | null | 2021-11-29 | 2021-11-29 | CHOP R | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101251176 |
| 10457629 | 10034703 | 1.7 | 118 | null | 2021-11-13 | 2021-11-18 | CAPECITABINE + OXALIPLATIN | 02 | null | DOCETAXEL | 101033082 |
| 10457648 | 10034704 | 1.73 | 59.3 | Palliative (P) | 2016-10-26 | 2016-10-27 | Capecitabine + Oxaliplatin 21day | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101536835 |
| 10457686 | 10034705 | 1.59 | 57 | Disease modification (D) | 2018-12-23 | 2018-12-26 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 100493344 |
| 10457701 | 10034706 | 1.59 | 77.1 | 03 | 2020-11-14 | 2020-12-09 | Capecitabine + Oxaliplatin 21day | 02 | null | DOCETAXEL | 100479278 |
| 10457708 | 10034707 | 1.68 | 0 | 03 | 2013-11-30 | 2017-04-15 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100665352 |
| 10457719 | 10034708 | 1.65 | 94 | Adjuvant (A) | 2014-10-17 | 2014-10-28 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 100990905 |
| 10457732 | 10034709 | 1.64 | 65 | Curative (C) | 2017-02-19 | 2017-03-02 | CAPECITABINE + OXALIPLATIN | 02 | Y | CAPECITABINE + OXALIPLATIN | 100462609 |
| 10457748 | 10034710 | 1.75 | 76.25 | null | 2021-02-27 | 2021-03-08 | CAPECITABINE + RT | 02 | null | CAPECITABINE | 101340098 |
| 10457749 | 10034711 | 1.82 | 68.7 | 03 | 2018-06-04 | 2018-06-18 | Capecitabine | 02 | N | CAPECITABINE | 101013262 |
| 10457794 | 10034712 | 1.66 | 50 | null | 2021-03-23 | 2021-03-31 | Rituximab | 2 | null | RITUXIMAB | 101087939 |
| 10457795 | 10034713 | 1.8 | 64.1 | Curative (C) | 2017-01-27 | 2017-01-28 | Capecitabine | 02 | N | CAPECITABINE | 101500036 |
| 10457809 | 10034714 | null | 0 | Curative (C) | 2015-11-06 | 2015-11-06 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101529627 |